biota's future, page-27

Give Indy his dues... there has been a political furore in places like France about the over-ordering of vaccines and masks. There might be political pressure, at least in the short term, to ease up on these types of expenditures which may spill over into anti-viral stockpiling... so it could very well be that the pandemic premium has disappeared but bta's share price by no means reflects the post-pandemic premium in which relenza (& later LANI) takes post-pandemic market share off Tamiflu...